Stock Analysis
- Japan
- /
- Medical Equipment
- /
- TSE:4595
Mizuho MedyLtd First Quarter 2024 Earnings: EPS: JP¥102 (vs JP¥78.33 in 1Q 2023)
Mizuho MedyLtd (TSE:4595) First Quarter 2024 Results
Key Financial Results
- Revenue: JP¥2.74b (up 15% from 1Q 2023).
- Net income: JP¥970.0m (up 30% from 1Q 2023).
- Profit margin: 35% (up from 31% in 1Q 2023). The increase in margin was driven by higher revenue.
- EPS: JP¥102 (up from JP¥78.33 in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Mizuho MedyLtd Earnings Insights
Looking ahead, revenue is expected to decline by 1.7% p.a. on average during the next 3 years, while revenues in the Medical Equipment industry in Japan are expected to grow by 6.3%.
Performance of the Japanese Medical Equipment industry.
The company's shares are up 1.8% from a week ago.
Risk Analysis
What about risks? Every company has them, and we've spotted 1 warning sign for Mizuho MedyLtd you should know about.
Valuation is complex, but we're helping make it simple.
Find out whether Mizuho MedyLtd is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:4595
Mizuho MedyLtd
Researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan.
Flawless balance sheet and undervalued.